Nine new dihydrochloride salts of 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-alkoxyethoxybenzoates were designed and synthesized. The physicochemical properties such as lipophilicity index (log kw) and dissociation constant (pKa) were experimentally determined and compared to the software calculated data. The lipophilicity index was determined by means of reversed-phase high performance liquid chromatography (RP-HPLC). The pKa values were determined by means of capillary zone electrophoresis. The "drug-likeness" properties according to the Lipinski Rule of Five and prediction of possible blood-brain barrier penetration were computed and discussed.

Department of Chemical Drugs Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences Palackeho 1 61242 Brno Czech Republic

Global Change Research Institute CAS Belidla 986 4a 60300 Brno Czech Republic

Zobrazit více v PubMed

Pedersen M.E., Cockcroft J.R. The vasodilatory Beta-blockers. Curr. Hypertens. Rep. 2007;9:269–277. doi: 10.1007/s11906-007-0050-2. PubMed DOI

Reiter M.-J. Cardiovascular Drug Class Specifity: β-blockers. Prog. Cardiovasc. Dis. 2004;47:11–33. doi: 10.1016/j.pcad.2004.04.004. PubMed DOI

Chiu C.C., Wu J.R., Lee C.H., Liou S.F., Dai Z.K., Chen I.J., Yeh J.L. Anti-Hypertension Effect of Vanylidilol: A Phenylaldehyde α/β-Adrenoceptor Blocker with Endothelium-Dependent and K+ Channels Opening-Associated Vasorelaxant Activities. Pharmacology. 2004;70:140–151. doi: 10.1159/000074977. PubMed DOI

Deák K., Takács-Novák K., Kapás M., Vastag M., Tihanyi K., Noszál B. Physico-chemical characterization of a novel group of dopamine D3/D2 receptor ligands, potential atypical antipsychotic agents. J. Pharm. Biomed. Anal. 2008;48:678–684. doi: 10.1016/j.jpba.2008.06.021. PubMed DOI

Tengler J., Kapustikova I., Stropnicky O., Mokry P., Oravec M., Csollei J., Jampilek J. Synthesis of new (arylcarbonyloxy)aminopropanol derivatives and the determination of their physico-chemical properties. Cent. Eur. J. Chem. 2013;11:1757–1767. doi: 10.2478/s11532-013-0302-8. DOI

Mälkiä A., Murtomäki L., Urtti A., Kontturi K. Drug permeation in biomembranes in vitro and in silico prediction and influence of physicochemical properties. Eur. J. Pharm. Sci. 2004;23:13–47. doi: 10.1016/j.ejps.2004.05.009. PubMed DOI

Alavijeh M.S., Chishty M., Qaiser M.Z., Palmer A.M. Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery. NeuroRx. 2005;2:554–571. doi: 10.1602/neurorx.2.4.554. PubMed DOI PMC

Duchowicz P.R., Castro E.A. QSPR studies on aqueous solubilities of drug-like compounds. Int. J. Mol. Sci. 2009;10:2558–2577. doi: 10.3390/ijms10062558. PubMed DOI PMC

Mannhold A., Waterbeemd H. Substructure and whole molecule approaches for calculating log P. J. Comput. Aided Mol. Des. 2001;15:337–354. doi: 10.1023/A:1011107422318. PubMed DOI

Giaginis C., Tsantili-Kakoulidou A. Current state of the art in HPLC methodology for lipophilicity assessment of basic drugs. A review. J. Liq. Chromatogr. Relat. Technol. 2008;31:79–96. doi: 10.1080/10826070701665626. DOI

Lombardo F., Shalaeva M.Y., Tupper K.A., Gao F. ElogDoct: A tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. J. Med. Chem. 2001;44:2490–2497. doi: 10.1021/jm0100990. PubMed DOI

Stella C., Galland A., Xiangli L., Testa B., Rudaz S., Veuthey J.L., Carrupt P.A. Novel RPLC stationary phases for lipophilicity measurement: Solvatochromic analysis of retention mechanisms for neutral and basic compounds. J. Sep. Sci. 2004;27:284–292. doi: 10.1002/jssc.200301671. PubMed DOI

Reijenga J., van Hoof A., van Loon A., Teunissen B. Development of methods for the determination of pKa Values. Anal. Chem. Insights. 2013;8:53–71. doi: 10.4137/ACI.S12304. PubMed DOI PMC

Kapustikova I., Tengler J. Determination of Acid-Base Dissociation Constant of Selected β-Blockers Using Capillary Zone Electrophoresis, RP-HPLC and 1H-NMR. Chem. Listy. 2014;108:1073–1079.

Poole S.K., Patel S., Dehring K., Workman H., Poole C.F. Determination of acid dissociation constants by capillary electrophoresis. J. Chromatogr. A. 2004;1037:445–454. doi: 10.1016/j.chroma.2004.02.087. PubMed DOI

Nowak P., Woźniakiewicz M., Kościelniak P. Application of capillary electrophoresis in determination of acid dissociation constant values. J. Chromatogr. A. 2015;1377:1–12. doi: 10.1016/j.chroma.2014.12.032. PubMed DOI

Andrasi M., Buglyo P., Zekany L., Gaspar A. A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants. J. Pharm. Biomed. Anal. 2007;44:1040–1047. doi: 10.1016/j.jpba.2007.04.024. PubMed DOI

Bodor N., Buchwald P. Soft drug design: General principles and recent applications. Med. Res. Rev. 2000;20:58–101. doi: 10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X. PubMed DOI

Handzlik J., Pertz H.H., Görnemann T., Jähnichen S., Kieć-Kononowicz K. Search for influence of spatial properties on affinity at α1-adrenoreceptor subtypes for phenylpiperazine derivatives of phenytoin. Bioorg. Med. Chem. Lett. 2010;20:6152–6156. doi: 10.1016/j.bmcl.2010.07.101. PubMed DOI

Wang Z., Pei Y., Zhao J., Li Z., Chen Y., Zhuo K. Formation of Ether-Functionalized Ionic-Liquid-Based Aqueous Two-Phase Systems and Their Application in Separation of Protein and Saccharides. J. Phys. Chem. B. 2015;119:4471–4478. doi: 10.1021/jp510984d. PubMed DOI

Colley H.E., Muthana M., Danson S.J., Jackson L.V., Brett M.L., Harrison J., Coole S.F., Mason D.P., Jennings L.R., Wong M., et al. An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. J. Med. Chem. 2015;58:9309–9333. doi: 10.1021/acs.jmedchem.5b01312. PubMed DOI

Ayme J.-F., Lux J., Sauvage J.-P., Sour A. Catenanes Built Around Octahedral Transition-Metal Complexes that Contain Two Intertwined Endocyclic but Non-sterically Hindering Tridentate Ligands. Chem. Eur. J. 2012;18:5565–5573. doi: 10.1002/chem.201104061. PubMed DOI

Ammazzalorso A., Amoroso R., Bettoni G., Fantacuzzi M., De Filippis B., Giampietro L., Maccallini C., Paludi D., Tricca M.L. Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid. Farmaco. 2004;59:685–690. doi: 10.1016/j.farmac.2004.05.002. PubMed DOI

Marvanova P., Padrtova T., Pekarek T., Brus J., Czernek J., Mokry P., Humpa O., Oravec M., Jampilek J. Synthesis and Characterization of New 3-(4-Arylpiperazin-1-yl)-2-hydroxypropyl 4-Propoxybenzoates and Their Hydrochloride Salts. Molecules. 2016;21:707. doi: 10.3390/molecules21060707. PubMed DOI PMC

McAinsh J., Cruickshank J.M. Beta-blockers and central nervous system side effects. Pharmacol. Ther. 1990;46:163–197. doi: 10.1016/0163-7258(90)90092-G. PubMed DOI

Clark D.E. In silico prediction of blood-brain barrier permeation. Drug Discov. Today. 2003;8:927–933. doi: 10.1016/S1359-6446(03)02827-7. PubMed DOI

Vilar S., Chakrabarti M., Costanzi S. Prediciton of passive blood-brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptors. J. Mol. Graph. Model. 2010;28:899–903. doi: 10.1016/j.jmgm.2010.03.010. PubMed DOI PMC

Palmer A.M., Alavijeh M.S. Translation CNS medicines research. Drug Discov. Today. 2012;17:1068–1078. doi: 10.1016/j.drudis.2012.05.001. PubMed DOI

Veber D.F., Johnson S.R., Cheng H.Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidate. J. Med. Chem. 2002;45:2615–2623. doi: 10.1021/jm020017n. PubMed DOI

Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J. Pharm. Sci. 1999;88:815–821. doi: 10.1021/js980402t. PubMed DOI

Hutter M.C. Prediction of blood–brain barrier permeation using quantum chemically derived information. J. Comput. Aided Mol. Des. 2003;17:415–433. doi: 10.1023/A:1027359714663. PubMed DOI

An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors